Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain "HEROIC"


Phase N/A Results N/A

Summary of Purpose

Depict demographic and clinical features of patients with atrial fibrillation treated with rivaroxaban to prevent stroke and pulmonary embolism in routine clinical practice

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 June 2015.

1 Oct 2014 9 Oct 2014 1 Feb 2015 1 May 2015 1 Jun 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Cross-Sectional
  • Sampling: Non-Probability Sample